ITT, Inc. ITT 深 滬
等待開盤 11-03 09:30:00 美东时间
185.07
-1.990
-1.06%
華盛通- 最 高188.2018
- 今 開187.04
- 成交量 56.17万股
- 最 低 184.22
- 昨 收 187.06
- 總市值 145.65亿
- 52周最高 197.07
- 市盈率 靜 29.39
- 換手率 0.71%
- 52周最低 104.938
- 委 比 4.92%
- 總股本 7870.00万
- 歷史最高 197.07
- 量 比 0.78
- 振 幅 2.13%
- 歷史最低 -6.0192
- 每 手 1
- 風險率 15.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多科技巨头豪赌AI！5000亿美元涌向数据中心产业链，这些概念股继续“起飞”？
科技巨头豪赌AI！5000亿美元投资涌向数据中心产业链，除了英伟达以外，美股还有哪些公司在“闷声发大财”？>>
10-31 17:17
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Keybanc Maintains Overweight on ITT, Raises Price Target to $215
Keybanc analyst Jeffrey D. Hammond maintains ITT (NYSE:ITT) with a Overweight and raises the price target from $200 to $215.
10-30 20:46
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Edesa Biotech Results From Phase 3 Trial Of Paridiprubart Meets Primary, Secondary Endpoints With Statistical Significance For Reduced Mortality At 28 Days
Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics (HDTs) for immuno-inflammatory diseases, today announced positive results from a Phase 3
10-28 19:50
Insights into Xylem's Upcoming Earnings
Xylem (NYSE:XYL) is set to give its latest quarterly earnings report on Tuesday...
10-28 00:01
2025年6月全球水泵品牌推荐：十强选择指南与市场报告
（来源：衡水日报） 转自：衡水日报 引言与现状分析 如果您正在为全球项目挑选水泵，大概率面临三重焦虑：一是工况复杂，清水、污水、高扬程...
10-23 15:08
Earnings Outlook For Graco
Graco (NYSE:GGG) is preparing to release its quarterly earnings on Wednesday, 2...
10-22 00:02
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
10-21 18:13
Stifel Maintains Buy on ITT, Raises Price Target to $203
Stifel analyst Nathan Jones maintains ITT (NYSE:ITT) with a Buy and raises the price target from $202 to $203.
10-20 22:56
公司簡介
公司名稱
|
ITT
|
行業分類
|
工业机械
|
業務描述
|
ITT, Inc. engages in the manufacture and sale of engineered components and customized technology solutions primarily for the transportation, industrial, and energy markets. It operates through the following segments: Motion Technologies (MT), Industrial Process (IP), and Connect and Control Technologies (CCT). The MT segment includes ITT Friction Technologies, Axtone, KONI, Novitek, Wolverine Advanced Materials, and GALT brands. The IP segment refers to Goulds Pumps, PRO Services, Rheinh tte Pumpen, Bornemann, C'treat, Habonim, Engineered Valves, and i-ALERT brands. The CCT segment is involved in the Cannon, Aerospace Controls, Neo-Dyn, VEAM, Enidine, Conoflow, BIW Connector Systems, Compact Automation, and Micro-Mode brands. The company was founded in 1920 and is headquartered in Stamford, CT.
|
科技巨头豪赌AI！5000亿美元涌向数据中心产业链，这些概念股继续“起飞”？
科技巨头豪赌AI！5000亿美元投资涌向数据中心产业链，除了英伟达以外，美股还有哪些公司在“闷声发大财”？>>
10-31 17:17
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Keybanc Maintains Overweight on ITT, Raises Price Target to $215
Keybanc analyst Jeffrey D. Hammond maintains ITT (NYSE:ITT) with a Overweight and raises the price target from $200 to $215.
10-30 20:46
Earnings Scheduled For October 29, 2025
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Edesa Biotech Results From Phase 3 Trial Of Paridiprubart Meets Primary, Secondary Endpoints With Statistical Significance For Reduced Mortality At 28 Days
Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics (HDTs) for immuno-inflammatory diseases, today announced positive results from a Phase 3
10-28 19:50
Insights into Xylem's Upcoming Earnings
Xylem (NYSE:XYL) is set to give its latest quarterly earnings report on Tuesday...
10-28 00:01
2025年6月全球水泵品牌推荐：十强选择指南与市场报告
（来源：衡水日报） 转自：衡水日报 引言与现状分析 如果您正在为全球项目挑选水泵，大概率面临三重焦虑：一是工况复杂，清水、污水、高扬程...
10-23 15:08
Earnings Outlook For Graco
Graco (NYSE:GGG) is preparing to release its quarterly earnings on Wednesday, 2...
10-22 00:02
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级
今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元
10-21 18:13
Stifel Maintains Buy on ITT, Raises Price Target to $203
Stifel analyst Nathan Jones maintains ITT (NYSE:ITT) with a Buy and raises the price target from $202 to $203.
10-20 22:56
派息除權日
|
每股總股息
| 派息日期 |
2025-12-01
|
0.35
|
2025-12-31
|
2025-09-02
|
0.35
|
2025-09-29
|
2025-06-02
|
0.35
|
2025-06-30
|
2025-03-06
|
0.35
|
2025-03-31
|
2024-11-29
|
0.32
|
2024-12-31
|
2024-09-03
|
0.32
|
2024-09-30
|
2024-06-03
|
0.32
|
2024-07-01
|
2024-03-07
|
0.32
|
2024-04-01
|
2023-11-30
|
0.29
|
2023-12-29
|
2023-08-31
|
0.29
|
2023-10-02
|
2023-06-08
|
0.29
|
2023-07-03
|
2023-03-08
|
0.29
|
2023-04-03
|
2022-11-30
|
0.26
|
2022-12-30
|
2022-09-01
|
0.26
|
2022-10-03
|
2022-06-16
|
0.26
|
2022-07-05
|
2022-03-08
|
0.26
|
2022-04-04
|
2021-12-10
|
0.22
|
2021-12-30
|
2021-09-10
|
0.22
|
2021-10-04
|
2021-06-18
|
0.22
|
2021-07-06
|
2021-03-16
|
0.22
|
2021-04-05
|
2020-12-04
|
0.17
|
2020-12-30
|
2020-09-10
|
0.17
|
2020-10-05
|
2020-06-12
|
0.17
|
2020-07-06
|
2020-03-13
|
0.17
|
2020-04-06
|
2019-12-06
|
0.15
|
2019-12-30
|
2019-09-09
|
0.15
|
2019-10-01
|
2019-06-07
|
0.15
|
2019-07-01
|
2019-03-08
|
0.15
|
2019-04-01
|
2018-12-06
|
0.13
|
2018-12-28
|
2018-09-07
|
0.13
|
2018-10-01
|
2018-06-08
|
0.13
|
2018-07-02
|
2018-03-09
|
0.13
|
2018-04-02
|
2017-12-07
|
0.13
|
2017-12-29
|
2017-09-08
|
0.13
|
2017-10-02
|
2017-06-08
|
0.13
|
2017-07-03
|
2017-03-09
|
0.13
|
2017-04-03
|
2016-12-07
|
0.12
|
2016-12-30
|
2016-09-07
|
0.12
|
2016-10-03
|
2016-06-08
|
0.12
|
2016-07-01
|
2016-03-09
|
0.12
|
2016-04-01
|
2015-12-09
|
0.12
|
2015-12-31
|
2015-09-09
|
0.12
|
2015-10-01
|
2015-06-10
|
0.12
|
2015-07-01
|
2015-03-11
|
0.12
|
2015-04-01
|
2014-12-10
|
0.11
|
2014-12-31
|
2014-09-10
|
0.11
|
2014-10-01
|
2014-06-11
|
0.11
|
2014-07-01
|
2014-03-12
|
0.11
|
2014-04-01
|
2013-11-13
|
0.10
|
2013-12-31
|
2013-08-28
|
0.10
|
2013-10-01
|
2013-05-22
|
0.10
|
2013-07-01
|
2013-03-13
|
0.10
|
2013-04-01
|
2012-11-15
|
0.09
|
2012-12-31
|
2012-08-29
|
0.09
|
2012-10-01
|
2012-05-23
|
0.09
|
2012-07-01
|
2012-03-05
|
0.09
|
2012-04-01
|
2011-11-08
|
0.09
|
2011-12-31
|
2011-08-24
|
0.25
|
2011-10-01
|
2011-05-18
|
0.25
|
2011-07-01
|
2011-02-28
|
0.25
|
2011-04-01
|
2010-11-09
|
0.25
|
2011-01-01
|
2010-08-25
|
0.25
|
2010-10-01
|
2010-05-19
|
0.25
|
2010-07-01
|
2010-03-01
|
0.25
|
2010-04-01
|
2009-11-10
|
0.21
|
2010-01-01
|
2009-08-19
|
0.21
|
2009-10-01
|
2009-05-20
|
0.21
|
2009-07-01
|
2009-03-02
|
0.21
|
2009-04-01
|
2008-11-12
|
0.17
|
2009-01-01
|
2008-08-20
|
0.17
|
2008-10-01
|
2008-05-21
|
0.17
|
2008-07-01
|
2008-03-05
|
0.17
|
2008-04-01
|
2007-11-14
|
0.14
|
2008-01-01
|
2007-08-22
|
0.14
|
2007-10-01
|
2007-05-16
|
0.14
|
2007-07-01
|
2007-03-07
|
0.14
|
2007-04-01
|
2006-11-15
|
0.11
|
2007-01-01
|
2006-08-23
|
0.11
|
2006-10-01
|
2006-05-17
|
0.11
|
2006-07-01
|
2006-03-08
|
0.11
|
2006-04-01
|
2005-11-16
|
0.18
|
2006-01-01
|
2005-08-24
|
0.18
|
2005-10-01
|
2005-05-18
|
0.18
|
2005-07-01
|
2005-03-09
|
0.18
|
2005-04-01
|
2004-11-17
|
0.17
|
2005-01-01
|
2004-08-25
|
0.17
|
2004-10-01
|
2004-05-19
|
0.17
|
2004-07-01
|
2004-03-10
|
0.17
|
2004-04-01
|
2003-11-19
|
0.16
|
2004-01-01
|
2003-08-27
|
0.16
|
2003-10-01
|
2003-05-21
|
0.16
|
2003-07-01
|
2003-03-12
|
0.16
|
2003-04-01
|
2002-11-20
|
0.15
|
2003-01-01
|
2002-08-28
|
0.15
|
2002-10-01
|
2002-05-22
|
0.15
|
2002-07-01
|
2002-03-13
|
0.15
|
2002-04-01
|
2001-11-28
|
0.15
|
2002-01-01
|
2001-08-29
|
0.15
|
2001-10-01
|
2001-05-23
|
0.15
|
2001-07-01
|
2001-03-14
|
0.15
|
2001-04-01
|
2000-11-20
|
0.15
|
2001-01-01
|
2000-08-23
|
0.15
|
2000-10-01
|
2000-05-24
|
0.15
|
2000-07-01
|
2000-02-23
|
0.15
|
2000-04-01
|
1999-11-22
|
0.15
|
2000-01-01
|
1999-08-25
|
0.15
|
1999-10-01
|
1999-05-26
|
0.15
|
1999-07-01
|
1999-02-24
|
0.15
|
1999-04-01
|
1998-11-23
|
0.15
|
1999-01-01
|
1998-08-26
|
0.15
|
1998-10-01
|
1998-05-27
|
0.15
|
1998-07-01
|
1998-05-26
|
0.15
|
1998-07-01
|
1998-02-25
|
0.15
|
1998-04-01
|
1997-11-25
|
0.15
|
1998-01-01
|
1997-08-27
|
0.15
|
1997-10-01
|
1997-05-28
|
0.15
|
1997-07-01
|
1997-02-26
|
0.15
|
1997-04-01
|
1996-11-13
|
0.15
|
1997-01-01
|
1996-08-07
|
0.15
|
1996-10-01
|
1996-05-15
|
0.15
|
1996-07-01
|
1996-02-21
|
0.15
|
1996-04-01
|
1994-07-01
|
0.10
|
1994-07-01
|
1994-04-05
|
0.09
|
1994-04-01
|
1994-01-03
|
0.08
|
1994-01-01
|
1993-10-01
|
0.08
|
1993-10-01
|
1993-07-01
|
0.08
|
1993-07-01
|
1993-04-01
|
0.09
|
1993-04-01
|
1993-01-04
|
0.08
|
1993-01-01
|
1992-10-01
|
0.09
|
1992-10-01
|
1992-07-01
|
0.09
|
1992-07-01
|
1992-04-01
|
0.08
|
1992-04-01
|
1992-01-02
|
0.08
|
1992-01-01
|
1991-10-01
|
0.07
|
1991-10-01
|
1991-07-01
|
0.07
|
1991-07-01
|
1991-04-02
|
0.07
|
1991-04-01
|
1991-01-02
|
0.08
|
1991-01-01
|
1990-10-01
|
0.07
|
1990-10-01
|
1990-07-02
|
0.07
|
1990-07-02
|
1990-04-02
|
0.07
|
1990-04-01
|
1990-01-02
|
0.07
|
1990-01-01
|
1989-10-01
|
0.06
|
1989-10-01
|
1989-07-01
|
0.05
|
1989-07-01
|
1989-04-01
|
0.06
|
1989-04-01
|
1989-01-01
|
0.06
|
1989-01-01
|
